血友病护理的范式转变:基因治疗的承诺
Safia Fathima Anver Pasha1, Tasnim Fathima Khalifa Anver1, Suresh Kumar Srinivasamurthy1
1RAK College of Medical Sciences (RAKCOMS), RAK Medical and Health Sciences University (RAKMHSU), Ras Al Khaimah, Al Qusaidat, United Arab Emirates.
Current gene therapy
|August 11, 2025
概括
基因疗法为血友病提供了一次性治疗,显著减少出血发作和因子替代的需要. 需要进一步的研究来确认长期的安全性和有效性.
科学领域:
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
- 生物技术是生物技术.
背景情况:
- 对包括血友病在内的罕见遗传疾病的基因疗法研究得到了加强.
- 传统的血友病治疗需要持续的因子替代,强调需要一次性,长期的解决方案.
研究的目的:
- 审查血友病基因疗法的当前潜力.
- 为了阐明血友病基因疗法的作用模式.
- 评估血友病基因疗法的长期有效性和临床意义.
主要方法:
- 在PubMed,Embase,Google Scholar和Scopus进行的文献搜索.
- 关键词包括:基因疗法,病毒载体,Roctavian,血友病,埃特拉纳基因 dezaparvovec,AAV和FIX-Padua变异.
主要成果:
- 美国食品和药物管理局批准的血友病A的基因疗法包括valoctocogene roxaparvovec (Roctavian).
- 美国食品和药物管理局批准的B型血友病的基因疗法包括以太诺基因desaparvovec (Hemgenix) 和费达诺基因elaparvovec (Beqvez).
- 马斯塔西马布 (Hympavzi) 是一种基于抗体的疗法,已批准用于血友病A和B.
结论:
- 基因疗法在血友病中表现出持续的成功,导致功能凝固因子 (第八或第九因子) 的长期表达.
- 临床试验显示出减少了出血发作和减少了对常规因子替代疗法的依赖.
- 进一步的研究对于评估这些基因疗法的长期安全性和有效性至关重要.
关键词:
AAV 矢量. 在 AAV 矢量.基因治疗是一种基因疗法.血流疾病 血流疾病凝血因子是什么 凝血因子是什么埃特拉诺基因 脱离 消失 消失血友病A型 血友病A型 血友病A型血友病 B 型 血友病 B 型血液静止 血液静止 血液静止值ctocogene 罗克萨帕尔沃维克更多相关视频
11:16Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
7.8K
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
14.4K
相关概念视频
Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
Microorganisms in Medicine and Therapeutics
330
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
330
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
What is Genetic Engineering?
75.5K
Overview
75.5K
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
